{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T15:54:42Z","timestamp":1791561282762,"version":"4.3.4"},"reference-count":86,"publisher":"MDPI AG","issue":"3","license":[{"start":{"date-parts":[[2023,3,21]],"date-time":"2023-03-21T00:00:00Z","timestamp":1679356800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Health and Labor Sciences Research Grant on Intractable Diseases (\u201cNeuroimmunological Diseases\u201d and \u201cClinical research for HAM\/TSP toward identification of new biomarkers and establishment of therapeutic strategies\u201d","award":["No. 24591267"],"award-info":[{"award-number":["No. 24591267"]}]},{"name":"Health and Labor Sciences Research Grant on Intractable Diseases (\u201cNeuroimmunological Diseases\u201d and \u201cClinical research for HAM\/TSP toward identification of new biomarkers and establishment of therapeutic strategies\u201d","award":["No. AS2211341G"],"award-info":[{"award-number":["No. AS2211341G"]}]},{"name":"Grant-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology in Japan","award":["No. 24591267"],"award-info":[{"award-number":["No. 24591267"]}]},{"name":"Grant-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology in Japan","award":["No. AS2211341G"],"award-info":[{"award-number":["No. AS2211341G"]}]},{"name":"Feasibility Study Stage of the Japan Science and Technology Agency (JST)","award":["No. 24591267"],"award-info":[{"award-number":["No. 24591267"]}]},{"name":"Feasibility Study Stage of the Japan Science and Technology Agency (JST)","award":["No. AS2211341G"],"award-info":[{"award-number":["No. AS2211341G"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pathogens"],"abstract":"<jats:p>Slowly progressive spastic paraparesis with bladder dysfunction, the main clinical feature of human T-cell leukemia virus-1 (HTLV-1)-associated myelopathy\/tropical spastic paraparesis (HAM\/TSP), is induced by chronic inflammation in the spinal cord, mainly the lower thoracic cord. A long-standing bystander mechanism, such as the destruction of surrounding tissues by inflammatory cytokines, etc., induced under the interaction between infiltrated HTLV-1-infected CD4+ T cells and HTLV-1-specific CD8+ cytotoxic T cells, has been considered implicated for the induction of chronic inflammation. As this bystander mechanism is triggered conceivably by the transmigration of HTLV-1-infected CD4+ T cells to the spinal cord, heightened transmigrating activity of HTLV-1-infected CD4+ T cells to the spinal cord might play a crucial role as the first responder in the development of HAM\/TSP. This review evaluated the functions of HTLV-1-infected CD4+ T cells in HAM\/TSP patients as the prerequisite for the acquisition of the activity such as adhesion molecule expression changes, small GTPases activation, and expression of mediators involved in basement membrane disruption. The findings suggest that HTLV-1-infected CD4+ T cells in HAM\/TSP patients have enough potential to facilitate transmigration into the tissues. Future HAM\/TSP research should clarify the molecular mechanisms leading to the establishment of HTLV-1-infected CD4+ T cells as the first responder in HAM\/TSP patients. In addition, a regimen with an inhibitory activity against the transmigration of HTLV-1-infected CD4+ T cells into the spinal cord might be recommended as one of the therapeutic strategies against HAM\/TSP patients.<\/jats:p>","DOI":"10.3390\/pathogens12030492","type":"journal-article","created":{"date-parts":[[2023,3,22]],"date-time":"2023-03-22T07:09:31Z","timestamp":1679468971000},"page":"492","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":24,"title":["HAM\/TSP Pathogenesis: The Transmigration Activity of HTLV-1-Infected T Cells into Tissues"],"prefix":"10.3390","volume":"12","author":[{"given":"Tatsufumi","family":"Nakamura","sequence":"first","affiliation":[{"name":"Department of Social Work, Faculty of Human and Social Studies, Nagasaki International University, Nagasaki 859-3298, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2023,3,21]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1016\/S0140-6736(86)91298-5","article-title":"HTLV-I associated myelopathy, a new clinical entity","volume":"327","author":"Osame","year":"1986","journal-title":"Lancet"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"389","DOI":"10.3389\/fmicb.2012.00389","article-title":"Clinical pathophysiology of human T-lymphotropic virus-type 1-associated myelopathy\/tropical spastic paraparesis","volume":"3","author":"Yamano","year":"2012","journal-title":"Front. Microbiol."},{"key":"ref_3","first-page":"1096","article-title":"The risk of development of HTLV-1-associated myelopathy\/tropical spastic paraparesis among persons infected with HTLV-1","volume":"3","author":"Kaplan","year":"1990","journal-title":"J. Acquir. Immune Defic. Syndr."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.1001\/archneur.63.11.1560","article-title":"Natural history of human T-lymphotropic virus 1-associated myelopathy: A 14-year follow-up study","volume":"63","author":"Olindo","year":"2006","journal-title":"Arch. Neurol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"15012","DOI":"10.1038\/nrdp.2015.12","article-title":"HTLV-1-associated myelopathy\/tropical spastic paraparesis","volume":"1","author":"Bangham","year":"2015","journal-title":"Nat. Rev. Dis. Primers"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/s12977-019-0499-5","article-title":"Immunovirological markers in HTLV-1-associated myelopathy\/tropical spastic paraparesis (HAM\/TSP)","volume":"16","author":"Jacobson","year":"2019","journal-title":"Retrovirology"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"614940","DOI":"10.3389\/fmicb.2020.614940","article-title":"Immunopathogenesis and cellular interactions in human T-cell leukemia virus type1 associated myelopathy\/tropical spastic paraparesis","volume":"11","author":"Aghajanian","year":"2020","journal-title":"Front. Microbiol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1086\/368379","article-title":"Different cytokine production in Tax-expressing cells between patients with human T cell lymphotropic virus type I (HTLV-I)-associated myelopathy\/tropical spastic paraparesis and asymptomatic HTLV-I carriers","volume":"187","author":"Furukawa","year":"2003","journal-title":"J. Infect. Dis."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"3431","DOI":"10.1172\/JCI75250","article-title":"HTLV-1 induces a Th1-like state in CD4+CCR4+ T cells","volume":"124","author":"Araya","year":"2014","journal-title":"J. Clin. Investig."},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"Yamano, Y., Araya, N., Sato, T., Utsunomiya, A., Azakami, K., Hasegawa, D., Izumi, T., Fujita, H., Aratani, S., and Yaggishita, N. (2009). Abnormally high levels of virus-infected IFN-g+CCR4+CD4+CD25+ Tcells in a retrovirus-associated neuroinflammatory disorder. PLoS ONE, 4.","DOI":"10.1371\/journal.pone.0006517"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1111\/j.1440-1789.2010.01135.x","article-title":"Neuropathology of HTLV-1-associated myelopathy (HAM\/TSP): The 50th Anniversary of Japanese Society of Neuropathology","volume":"30","author":"Izumo","year":"2010","journal-title":"Neuropathology"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1016\/0306-9877(93)90111-3","article-title":"An autoaggressive Process against bystander tissues in HTLV-I-infected individuals: A possible pathomechanism of HAM\/TSP","volume":"41","author":"Ijichi","year":"1993","journal-title":"Med. Hypotheses"},{"key":"ref_13","first-page":"182","article-title":"HTLV-I-associated myelopathy\/tropical spastic paraparesis (HAM\/TSP): The role of HTLV-I-infected Th1 cells in the pathogenesis, and therapeutic strategy","volume":"47","author":"Nakamura","year":"2009","journal-title":"Folia Neuropathol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1099\/vir.0.80766-0","article-title":"A functional CD8+ cell assay reveals individual variation in CD8+ cell antiviral efficacy and explains differences in human T-lymphotropic virus type 1 proviral load","volume":"86","author":"Asquith","year":"2005","journal-title":"J. Gen. Virol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"482","DOI":"10.4049\/jimmunol.161.1.482","article-title":"Demonstration of human T lymphotropic virus type I (HTLV-I) tax-specific CD8+ lymphocytes directly in peripheral blood of HTLV-I-associated myelopathy\/tropical spastic paraparesis patients by intracellular cytokine detection","volume":"161","author":"Kubota","year":"1998","journal-title":"J. Immunol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"2876","DOI":"10.1093\/brain\/awt183","article-title":"Positive feedback loop via astrocytes causes chronic inflammation in virus-associated myelopathy","volume":"136","author":"Ando","year":"2013","journal-title":"Brain"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1002\/ana.10065","article-title":"Increased HTLV-I proviral load and preferential expansion of HTLV-I tax-specific CD8+ T cells in cerebrospinal fluid from patients with HAM\/TSP","volume":"50","author":"Nagai","year":"2001","journal-title":"Ann. Neurol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1830","DOI":"10.1086\/429962","article-title":"Human T lymphotropic virus type I (HTLV-I) proviral load in cerebrospinal fluid: A new criterion for the diagnosis of HTLV-I-associated myelopathy\/tropical spastic paraparesis?","volume":"191","author":"Lezin","year":"2005","journal-title":"J. Infect. Dis."},{"key":"ref_19","unstructured":"Roman, G.C., Vernant, J.-C., and Osame, M. (1989). HTLV-I and the Nervous System, Alan R. Liss."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1007\/s004019900170","article-title":"Histopathological analysis of four autopsy cases of HTLV-I-associated myelopathy\/tropical spastic paraparesis: Inflammatory changes occur simultaneously in the entire central nervous system","volume":"100","author":"Aye","year":"2000","journal-title":"Acta Neuropathol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1007\/s11481-010-9216-9","article-title":"Neuroimmunity of HTLV-I infection","volume":"5","author":"Matsuura","year":"2010","journal-title":"J. Neuroimmune Pharmacol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.3390\/v3081439","article-title":"Cell surface markers in HTLV-1 pathogenesis","volume":"3","author":"Kress","year":"2011","journal-title":"Viruses"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/0092-8674(94)90337-9","article-title":"Traffic signals for lymphocyte recirculation and leukocyte emigration: The multiple step paradigm","volume":"76","author":"Springer","year":"1994","journal-title":"Cell"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"525","DOI":"10.4049\/jimmunol.155.2.525","article-title":"Leukocyte interactions with vascular endothelium. New insights into selectin-mediated attachment and rolling","volume":"155","author":"Ley","year":"1995","journal-title":"J. Immunol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"67","DOI":"10.4161\/cam.28244","article-title":"Rho-GTPase signaling in leukocyte extravasation: An endothelial point of view","volume":"8","author":"Heemskerk","year":"2014","journal-title":"Cell Adhes. Migr."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"7390","DOI":"10.1073\/pnas.91.16.7390","article-title":"Selectin ligands","volume":"91","author":"Varki","year":"1994","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/S0165-5728(02)00042-5","article-title":"Increased sialyl Lewisx antigen-positive cells mediated by HTLV-I infection in peripheral blood CD4+ T lymphocytes in patients with HTLV-I-associated myelopathy","volume":"125","author":"Kambara","year":"2002","journal-title":"J. Neuroimmunol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"151236","DOI":"10.1016\/j.ejcb.2022.151236","article-title":"The interface between biochemical signaling and cell mechanics shapes T lymphocyte migration and activation","volume":"101","year":"2022","journal-title":"Eur. J. Cell Biol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1001\/archneur.1992.00530250078019","article-title":"Increased adherence of T cells to human endothelial cells in patients with human T-cell lymphotropic virus type I-associated myelopathy","volume":"49","author":"Ichinose","year":"1992","journal-title":"Arch. Neurol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/0022-510X(94)90299-2","article-title":"Characterization of adherent T cells to human endothelial cells in patients with HTLV-I-associated myelopathy","volume":"122","author":"Ichinose","year":"1994","journal-title":"J. Neurol. Sci."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/S0171-2985(97)80065-4","article-title":"Characterization of T cells transmigrating through human endothelial cells in patients with HTLV-I-associated myelopathy","volume":"196","author":"Ichinose","year":"1996","journal-title":"Immunobiology"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"6021","DOI":"10.1128\/JVI.74.13.6021-6030.2000","article-title":"Interactions between brain endothelial cells and human T-cell leukemia virus type 1-infected lymphocytes: Mechanisms of viral entry into the central nervous system","volume":"74","author":"Romero","year":"2000","journal-title":"J. Virol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"2576","DOI":"10.4049\/jimmunol.179.4.2576","article-title":"Human blood-brain barrier disruption by retroviral-infected lymphocytes: Role of myosin light chain kinase in endothelial tight-junction disorganization","volume":"179","author":"Afonso","year":"2007","journal-title":"J. Immunol."},{"key":"ref_34","doi-asserted-by":"crossref","unstructured":"Afonso, P.V., Ozden, S., Cumont, M.-C., Seilhaean, D., Cartier, L., Rezaie, P., Mason, S., Lambert, S., Huerre, M., and Gessain, A. (2008). Alteration of blood-brain barrier integrity by retroviral infection. PLoS Pathog., 4.","DOI":"10.1371\/journal.ppat.1000205"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"7303","DOI":"10.1128\/JVI.00539-16","article-title":"Human T-lymphotropic virus type 1-induced overexpression of activated leukocyte cell adhesion molecule (ALCAM) facilitates trafficking of infected lymphocytes through the blood-brain barrier","volume":"90","author":"Curis","year":"2016","journal-title":"J. Virol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"17","DOI":"10.3960\/jslrt.52.17","article-title":"CADM1\/TSLC1 is a novel cell surface marker for adult T-cell leukemia\/lymphoma","volume":"52","author":"Nakahata","year":"2012","journal-title":"J. Clin. Exp. Hematop."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"532","DOI":"10.3324\/haematol.2019.234096","article-title":"Clinical significance of soluble CADM1 as a novel marker for adult T-cell leukemia\/lymphoma","volume":"106","author":"Nakahata","year":"2021","journal-title":"Haematologica"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1007\/s13365-020-00838-z","article-title":"Expression of TSLC1 in patients with HAM\/TSP","volume":"26","author":"Takenouchi","year":"2020","journal-title":"J. NeuroVirol."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1007\/s004010050435","article-title":"Expression of adhesion molecules and monocyte chemoattractant protein-1 (MCP-1) in the spinal cord lesions in HTLV-I-associated myelopathy","volume":"91","author":"Umehara","year":"1996","journal-title":"Acta Neuropathol."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1159\/000507086","article-title":"CD49d is upregulated in circulating T lymphocytes from HTLV-1-infected patients","volume":"27","author":"Vallinoto","year":"2020","journal-title":"Neuroimmunomodulation"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"e00608","DOI":"10.1128\/JVI.00608-19","article-title":"Human T-cell leukemia virus type 1 (HTLV-1) bZIP factor upregulates the expression of ICAM-1 to facilitate HTLV-1 infection","volume":"93","author":"Fazio","year":"2019","journal-title":"J. Virol."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1146\/annurev.cellbio.011209.122036","article-title":"Mechanical integration of actin and adhesion dynamics in cell migration","volume":"26","author":"Gardel","year":"2010","journal-title":"Annu. Rev. Cell Dev. Biol."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1074\/jbc.M310069200","article-title":"Protein profile of tax-associated complexes","volume":"279","author":"Wu","year":"2004","journal-title":"J. Biol. Chem."},{"key":"ref_44","doi-asserted-by":"crossref","unstructured":"Chevalier, S.A., Turpin, J., Cachat, A., Afonso, P.V., Gessain, A., Brady, J.N., Pise-Masison, C.A., and Mahieux, R. (2014). Gem-induced cytoskeleton remodeling increases cellular migration of HTLV-1-infected cells, formation of infected-to-target T-cell conjugates and viral transmission. PLoS Pathog., 10.","DOI":"10.1371\/journal.ppat.1003917"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/S0955-0674(03)00109-1","article-title":"Integrin signaling to the actin cytoskeleton","volume":"15","author":"DeMali","year":"2003","journal-title":"Curr. Opin. Cell Biol."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1097\/01.moh.0000147892.83713.a7","article-title":"Trading spaces: Rap, Rac, and Rho as architects of transendothelial migration","volume":"12","author":"Wittchen","year":"2005","journal-title":"Curr. Opin. Hematol."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1159\/000139130","article-title":"HTLV-I production based on activation of integrin\/ligand signaling in HTLV-I-infected T cell lines derived from HAM\/TSP patients","volume":"51","author":"Fukushima","year":"2008","journal-title":"Intervirology"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/S0092-8674(01)00471-8","article-title":"Integrin-mediated activation of Cdc42 controls cell polarity in migrating astrocytes through PKCzeta","volume":"106","author":"Hall","year":"2001","journal-title":"Cell"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1242\/jcs.01115","article-title":"Cdc42\u2014The centre of polarity","volume":"117","year":"2004","journal-title":"J. Cell Sci."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1083\/jcb.201003091","article-title":"Cdc42 localization and cell polarity depend on membrane traffic","volume":"191","author":"Osmani","year":"2010","journal-title":"J. Cell Biol."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1111\/j.1365-2567.2005.02214.x","article-title":"Regulation of immune cell adhesion and migration by regulator of adhesion and cell polarization enriched in lymphoid tissues","volume":"116","author":"Kinashi","year":"2005","journal-title":"Immunology"},{"key":"ref_52","doi-asserted-by":"crossref","unstructured":"Kondo, N., Ueda, Y., and Kinashi, T. (2022). LFA1 activation: Insights from a single-molecule approach. Cells., 11.","DOI":"10.3390\/cells11111751"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1111\/cen3.12278","article-title":"Involvement of C\u2013X-C chemokine receptor type 4 signaling in the efficiency of intercellular transmission of human T-lymphotropic virus type I","volume":"7","author":"Nakamura","year":"2016","journal-title":"Clin. Exp. Neuroimmunol."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1089\/aid.2017.0261","article-title":"Role of integrin signaling activation on the development of human T cell leukemia Virus-1 (HTLV-1)-associated myelopathy\/tropical spastic paraparesis: Its relationship to HTLV-1-infected CD4+ T cell transmigrating activity into the tissues","volume":"34","author":"Nakamura","year":"2018","journal-title":"AIDS Res. Hum. Retrovir."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1016\/0955-0674(93)90040-W","article-title":"Structural biochemistry and activation of metalloproteinases","volume":"5","author":"Kleiner","year":"1993","journal-title":"Curr. Opin. Cell Biol."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1097\/00005072-199809000-00005","article-title":"Expression of matrix metalloproteinases and tissue inhibitors of metalloproteinases in HTLV-I-associated myelopathy","volume":"57","author":"Umehara","year":"1998","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1089\/08892220050058380","article-title":"Tissue inhibitor of metalloproteinase 3, matrix metalloproteinase 9, and neopterin in the cerebrospinal fluid: Preferential presence in HTLV type I-infected neurologic patients versus healthy virus carriers","volume":"16","author":"Lezin","year":"2000","journal-title":"AIDS Res. Hum. Retrovir."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/S0165-5728(02)00100-5","article-title":"Selective matrix metalloproteinase inhibitor, N-biphenyl sulfonyl phenylalanine hydroxamic acid, inhibits the migration of CD4+ T lymphocytes in patients with HTLV-I-associated myelopathy","volume":"127","author":"Ikegami","year":"2002","journal-title":"J. Neuroimmunol."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"954103","DOI":"10.3389\/fimmu.2022.954103","article-title":"TNF-induced metalloproteinase-9 production is associated with neurological manifestations in HTLV-1-infected individuals","volume":"13","author":"Guerra","year":"2022","journal-title":"Front. Immunol."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"949516","DOI":"10.3389\/fimmu.2022.949516","article-title":"Chitotriosidase 1 in the cerebrospinal fluid as a putative biomarker for HTLV-1-associated myelopathy\/tropical spastic paraparesis (HAM\/TSP) progression","volume":"13","author":"Gomes","year":"2022","journal-title":"Front. Immunol."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1002\/acn3.169","article-title":"A plasma diagnostic model of human T-cell leukemia virus-1 associated myelopathy","volume":"2","author":"Ishihara","year":"2015","journal-title":"Ann. Clin. Transl. Neurol."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1093\/jnen\/60.4.320","article-title":"Production of MMPs in human cerebral endothelial cells and their role in shedding adhesion molecules","volume":"60","author":"Hummel","year":"2001","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"166170","DOI":"10.1016\/j.bbadis.2021.166170","article-title":"VCAM-1 as a predictor biomarker in cardiovascular disease","volume":"1867","author":"Troncoso","year":"2021","journal-title":"Biochim. Biophys. Acta Mol. Basis Dis."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/S0165-5728(99)00110-1","article-title":"Vascular cell adhesion molecule-1-mediated matrix metalloproteinase-2 induction in peripheral blood T cells is up-regulated in patients with HTLV-I-associated myelopathy","volume":"99","author":"Kambara","year":"1999","journal-title":"J. Neuroimmunol."},{"key":"ref_65","first-page":"228","article-title":"Heightened transmigrating activity of CD4-positive T cells through reconstituted basement membrane in patients with human T-lymphotropic virus type I-associated myelopathy","volume":"109","author":"Furuya","year":"1997","journal-title":"Proc. Assoc. Am. Phys."},{"key":"ref_66","doi-asserted-by":"crossref","unstructured":"Verhulst, E., Garnier, D., De Meester, I., and Bauvois, B. (2022). Validating cell surface proteases as drug targets for cancer therapy: What do we know, and where do we go?. Cancers, 14.","DOI":"10.3390\/cancers14030624"},{"key":"ref_67","doi-asserted-by":"crossref","unstructured":"Nakamura, H., Tsukamoto, M., Nagasawa, Y., Kitamura, N., Shimizu, T., Kawakami, A., Nagata, K., and Takei, M. (2022). Does HTLV-1 infection show phenotypes found in Sj\u00f6gren\u2019s syndrome?. Viruses, 14.","DOI":"10.3390\/v14010100"},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1097\/nen.0b013e31815f38b7","article-title":"Inclusion body myositis associated with human T-lymphotropic virus-type I infection: Eleven patients from an endemic area in Japan","volume":"67","author":"Matsuura","year":"2008","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"388","DOI":"10.3389\/fmicb.2020.00388","article-title":"HTLV-1 in ophthalmology","volume":"11","author":"Kamoi","year":"2020","journal-title":"Front. Microbiol."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"914498","DOI":"10.3389\/fimmu.2022.914498","article-title":"An overview of human T-lymphotropic virus Type 1 lung injury","volume":"13","author":"Dias","year":"2022","journal-title":"Front. Immunol."},{"key":"ref_71","doi-asserted-by":"crossref","unstructured":"Umekita, K. (2022). Effect of HTLV-1 infection on the clinical course of patients with rheumatoid arthritis. Viruses, 14.","DOI":"10.3390\/v14071460"},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1111\/exd.12007","article-title":"HTLV-1-associated infective dermatitis: Updates on the pathogenesis","volume":"21","author":"McGill","year":"2012","journal-title":"Exp. Dermatol."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1111\/j.1349-7006.1992.tb00132.x","article-title":"Novel complications with HTLV-1-associated myelopathy\/tropical spastic paraparesis: Interstitial cystitis and persistent prostatitis","volume":"83","author":"Nomata","year":"1992","journal-title":"Jpn. J. Cancer Res."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/S0022-510X(98)00066-5","article-title":"HTLV-I-associated myelopathy associated with multi-organ inflammatory disease: A case report","volume":"157","author":"Furuya","year":"1998","journal-title":"J. Neurol. Sci."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1001\/archneur.1996.00550090152022","article-title":"Human T-cell lymphotropic virus type 1-associated myelopathy, Sj\u00f6gren syndrome, and lymphocytic pneumonitis","volume":"53","author":"Kompoliti","year":"1996","journal-title":"Arch. Neurol."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1136\/ard.56.3.167","article-title":"High prevalence of Sj\u00f6gren\u2019s syndrome in patients with HTLV-I associated myelopathy","volume":"56","author":"Nakamura","year":"1997","journal-title":"Ann. Rheum. Dis."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"2633","DOI":"10.1002\/1529-0131(200111)44:11<2633::AID-ART443>3.0.CO;2-9","article-title":"Ectopic expression of the B cell-attracting chemokine BCA-1 (CXCL13) on endothelial cells and within lymphoid follicles contributes to the establishment of germinal center-like structures in Sj\u00f6gren\u2019s syndrome","volume":"44","author":"Amft","year":"2001","journal-title":"Arthritis Rheum."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1093\/rheumatology\/kep072","article-title":"Low prevalence of ectopic germinal centre formation in patients with HTLV-I-associated Sjogren\u2019s syndrome","volume":"48","author":"Nakamura","year":"2009","journal-title":"Rheumatology"},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/S0049-0172(99)80021-3","article-title":"The pathobiology of osteoarthritis and the rationale for the use of pentosan polysulfate for its treatment","volume":"28","author":"Ghosh","year":"1999","journal-title":"Semin. Arthritis Rheum."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"12692","DOI":"10.1128\/JVI.79.20.12692-12702.2005","article-title":"Heparan sulfate proteoglycans mediate attachment and entry of human T-cell leukemia virus type 1 virions into CD4+ T cells","volume":"79","author":"Jones","year":"2005","journal-title":"J. Virol."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"89","DOI":"10.3851\/IMP1699","article-title":"Fucoidan therapy decreases the proviral load in patients with human T-lymphotropic virus type-1-associated neurological disease","volume":"16","author":"Araya","year":"2011","journal-title":"Antivir. Ther."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"e00413","DOI":"10.1128\/JVI.00413-19","article-title":"Pentosan polysulfate demonstrates anti-human T-cell leukemia virus Type 1 activities in vitro and in vivo","volume":"93","author":"Ma","year":"2019","journal-title":"J. Virol."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/0022-510X(93)90220-S","article-title":"Heparin treatment in patients with human T-lymphotropic virus type I (HTLV-I)-associated myelopathy: A preliminary study","volume":"115","author":"Nagasato","year":"1993","journal-title":"J. Neurol. Sci."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1007\/s13365-014-0244-8","article-title":"Pentosan polysulfate treatment ameliorates motor function with increased serum soluble vascular cell adhesion molecule-1 in HTLV-1-associated neurologic disease","volume":"20","author":"Nakamura","year":"2014","journal-title":"J. Neurovirol."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1038\/s41573-021-00284-4","article-title":"Emerging therapeutic opportunities for integrin inhibitors","volume":"21","author":"Slack","year":"2022","journal-title":"Nat. Rev. Drug. Discov."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1042\/BST20210112","article-title":"Progress in the therapeutic inhibition of Cdc42 signalling","volume":"49","author":"Murphy","year":"2021","journal-title":"Biochem. Soc. Trans."}],"container-title":["Pathogens"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2076-0817\/12\/3\/492\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T18:59:51Z","timestamp":1760122791000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2076-0817\/12\/3\/492"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,21]]},"references-count":86,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2023,3]]}},"alternative-id":["pathogens12030492"],"URL":"https:\/\/doi.org\/10.3390\/pathogens12030492","relation":{},"ISSN":["2076-0817"],"issn-type":[{"value":"2076-0817","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,3,21]]}}}